AI-Driven Treatment Strategy vs Pola-R-CHP in Untreated LBCL

Clinical trial NCT07594899 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07594899
Sponsor: Ruijin Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Large B-Cell Lymphoma (LBCL)

Start date: 2026-05-06
Primary completion: 2029-05-31
Enrollment: 178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.